When Will Multiplex Tissue Imaging Start Being Used as a Clinical Tool?
The field of multiplex tissue imaging has been growing quickly over the last few years with a focus on [...]
Antibody Validation and the Visikol Multiplex Platform
In the 21st century, modern medicine has become more and more complex with an ever-growing need for researchers to [...]
An Introduction to ImageJ Macros
When performing research, it is common to analyze multiple replicates per group in order to gain statistical significance in [...]
Mouse Brain Slices for Tissue Clearing Sample Preparation
Visikol began as a products-oriented company with the development of the Visikol® tissue clearing reagents back in 2012. Since [...]
HUREL Micro Liver Overview Webinar
Visikol's CEO Michael Johnson, Ph.D. gives an overview of Visikol's HUREL Micro Liver products and services. [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]
HUREL Model Micro Livers and Hepatitis B
While hepatitis B infection is preventable by a well-established vaccine, the disease has proven to be [...]
HUREL® Micro Liver Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds
Mike Johnson2021-10-14T13:56:34-05:00Drug metabolism and pharmacokinetic (DMPK) scientists are tasked with the determination of various parameters to predict human PK. Their [...]
Improved Prediction of Hepatotoxicity (or DILI) Using HUREL® Hepatic Co-cultures
Mike Johnson2021-10-14T13:24:22-05:00Hepatotoxicity (liver cell toxicity) is one of the major causes of drug attrition during clinical development and withdrawal post-marketing. [...]
Making Precision Cut Tissue Slices Webinar
'Making Precision Cut Tissue Slices for Ex Vivo Assay Services' webinar was given in partnership with Precisionary Instruments. [...]